IMU-935: Phase 1 SAD/MAD Data in Healthy Human Subjects and Preclinical Update
December 14, 2021Tuesday, December 14, 2021B&T Cell-Mediated Autoimmune Disease Drug Development Summit
October 22, 2021Wednesday, October 6, 2021Virtual R&D Day: Update on the Preclinical and Clinical Development of IMU-935
October 22, 2021Monday, July 12, 2021IMU-838 in Multiple Sclerosis: Phase 3 Program in RRMS & Phase 2 Trial in PMS
October 22, 2021Thursday, July 1, 2021Main Phase 2 Analysis IMU-838 in Moderate COVID-19 & Phase 2 Proof-of-Concept Study IMU-838 in PSC
October 21, 2021February 18, 2021IBD Innovate Conference: Product Development for Crohn’s and Colitis
October 21, 2021Wednesday, December 4, 2019New York